Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients by Giusti Betti, Gori Anna Maria, Marcucci Rossella, Saracini Claudia, Sestini Ilaria, Paniccia Rita, Valente Serafina, Antoniucci Davide, Abbate Rosanna, Gensini Gian Franco in Pharmacogenetics and genomics (2007).

[PMID: 18004210] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.